Emile Loria
Chairman chez Portable Genomics, Inc.
Fortune : 14 M $ au 31/03/2024
Profil
Emile Loria is the founder of Ms Medical Synergy SA, founded in 1986.
He is also the founder of Orphan Synergy Europe-Pharma SA, founded in 2004, and OSE Immunotherapeutics SA, founded in 2012.
Dr. Loria's current job is Chairman & President at Portable Genomics, Inc. and Chairman at Dendrogenix SA. His former jobs include President & Chief Executive Officer at Epimmune, Inc. from 2001 to 2005, Principal at Sanofi and Novartis Corp., Principal at Biovector Therapeutics SA, and President at IDM Pharma, Inc. from 2001 to 2006.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OSE IMMUNOTHERAPEUTICS SA
12,17% | 05/02/2024 | 2 648 749 ( 12,17% ) | 14 M $ | 31/03/2024 |
Postes actifs de Emile Loria
| Sociétés | Poste | Début |
|---|---|---|
| Portable Genomics, Inc. | Chairman | - |
Dendrogenix SA
 Dendrogenix SA Pharmaceuticals: MajorHealth Technology Dendrogenix SA is a Belgian Belgium-based biotech company founded in 2018 that designs, develops, and brings proprietary molecules called dendrogenins to patients in the fields of hearing loss and neurology. The company is based in Liege, Belgium. Dendrogenins are cholesterol derivatives that stimulate cell differentiation in the immune and nervous system and induce growth of dendrites on dendritic cell and neuron precursors. The company has developed strong know-how in the chemical and biological aspects of dendrogenins. The company was founded by Stéphane Silvente, Gérard Tobelem, and Philippe Lefèbvre, with Stéphane Silvente serving as CEO since 2018. | Chairman | - |
Anciens postes connus de Emile Loria
| Sociétés | Poste | Fin |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Founder | 03/01/2018 |
IDM Pharma, Inc.
 IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology IDM Pharma, Inc. develops products for the destruction of cancer cells. Its products activate the immune system or prevent recurrence by triggering adaptive immune response. The company was founded in established on October 1987 and is headquartered in Cambridge, MA. | President | 09/01/2006 |
| Epimmune, Inc. | President | 17/08/2005 |
Ms Medical Synergy SA
 Ms Medical Synergy SA Pharmaceuticals: MajorHealth Technology Ms Medical Synergy SA develops pharmaceutical products. It provides materials and products for the medical industry. The firm also offers seminars for the pharmaceutical area. The company was founded on February 3, 1986 and is headquartered in Geneva, Switzerland. | Founder | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SANOFI | Health Technology |
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| Entreprise privées | 8 |
|---|---|
| Epimmune, Inc. | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Biovector Therapeutics SA
 Biovector Therapeutics SA Pharmaceuticals: MajorHealth Technology Biovector Therapeutics SA develops products for the prevention and treatment of infectious diseases and cancer. The private company is based in Labege, France. and has subsidiaries in France. | Health Technology |
IDM Pharma, Inc.
IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology IDM Pharma, Inc. develops products for the destruction of cancer cells. Its products activate the immune system or prevent recurrence by triggering adaptive immune response. The company was founded in established on October 1987 and is headquartered in Cambridge, MA. | Health Technology |
Orphan Synergy Europe-Pharma SA
 Orphan Synergy Europe-Pharma SA Pharmaceuticals: MajorHealth Technology Orphan Synergy Europe-Pharma SA engages in the development of immunotherapy products against late stage cancer. Its products include Tedopi as treatment for lung cancer and Memopi technology which helps the immune system to eliminate malignant cells. The company was founded by Dominique Costantini and Emile Loria on November 17, 2004 and is headquartered in Paris, France. | Health Technology |
| Portable Genomics, Inc. | |
Dendrogenix SA
Dendrogenix SA Pharmaceuticals: MajorHealth Technology Dendrogenix SA is a Belgian Belgium-based biotech company founded in 2018 that designs, develops, and brings proprietary molecules called dendrogenins to patients in the fields of hearing loss and neurology. The company is based in Liege, Belgium. Dendrogenins are cholesterol derivatives that stimulate cell differentiation in the immune and nervous system and induce growth of dendrites on dendritic cell and neuron precursors. The company has developed strong know-how in the chemical and biological aspects of dendrogenins. The company was founded by Stéphane Silvente, Gérard Tobelem, and Philippe Lefèbvre, with Stéphane Silvente serving as CEO since 2018. | Health Technology |
Ms Medical Synergy SA
Ms Medical Synergy SA Pharmaceuticals: MajorHealth Technology Ms Medical Synergy SA develops pharmaceutical products. It provides materials and products for the medical industry. The firm also offers seminars for the pharmaceutical area. The company was founded on February 3, 1986 and is headquartered in Geneva, Switzerland. | Health Technology |
